Abstract
This year's Rx and Illicit Drug Summit drew 4,000 participants to the Georgia World Congress Center in Atlanta last week; there were 100 exhibitors, and the pparticipants included ounselors, social workers, therapists, psychologists, and interventionists; physicians, psychiatrists, nurses, pharmacists, and dentists; advocates, families, and people in recovery; law enforcement and other first responders; state and federal lawmakers; and public health and prevention professionals. ADAW was able to pick up many new stories and meet with old friends and colleagues. The conference was also the setting for an announcement about a new emerging threat — fentanyl combined with xylazine (https://onlinelibrary.wiley.com/doi/10.1002/adaw.33205).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
